insights_auto
Why is BOT down 20,00%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080 A$
arrow_downward
-20,00%(-0,0020) 1D
20 қар., 16:10:07 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,01 A$
High
0,01 A$
Low
0,01 A$
Mkt. cap
22,10 млн
Avg. vol.
11,07 млн
Volume
8,60 млн
52-wk high
0,15 A$
52-wk low
0,01 A$
EPS
-0,03 A$
Shares outstanding
2,76 млрд
No. of employees
11
Open
0,01 A$
High
0,01 A$
Low
0,01 A$
Mkt. cap
22,10 млн
Avg. vol.
11,07 млн
Volume
8,60 млн
52-wk high
0,15 A$
52-wk low
0,01 A$
EPS
-0,03 A$
Shares outstanding
2,76 млрд
No. of employees
11
News stories
From web sources and news partners
NPR
·
30 минут бұрын
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
WSJ
·
12 сағат бұрын
S&P 500 Flirts With Correction
Barron's
·
4 сағат бұрын
S&P 500’s Tech Sector Crosses Bear Market Threshold
Los Angeles Times
·
5 сағат бұрын
S&P 500 falls 10% from record, entering correction as AI trade unravels
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com